Key Pieces Of Lung Cancer Survival Rate

Category:

By Anne Durrell

It is not easy to understand the figures about the lung cancer survival rate.

You really have to understand how these are put together and what exactly they represent.

All the figures you see may not be exactly what you think since there are many factors that influence how the lung cancer survival rates are determined.

The Basics

Lung cancer survival rates statements refer to a group of people at certain age suffering from lung cancer with some specific types of cancer.

It may also indicate rates for people suffering from lung cancer at any disease.

Usually the survival statistics relate to the survival rate after 5 years, no matter if the person still has cancer or is in remission.

It is important that you understand these statistics are based upon a large group and are averages. They can predict what the survival rate will be for any particular person, as every case is different.

Lung Cancer Survival Rate Factors

As I have written above that, many things influence the lung cancer survival rate statistics. Below are some factors that can alter survival rates area:

* Cancer Stage

* The type

* Signs present

* General health conditions

* Diagnosis date

When a doctor informs his patient on the possible outcome of their cancer diagnosis, he usually give it upon what happens in the average case.

It is really an estimate and not an exact science.

The Average of Lung Cancer Survival Rate

For those diagnosed with early stage of lung cancer, the average survival rate is 49%, which means out of 100 people only 49 live for at least five years after diagnosis.

On the other hand, people diagnosed with lung cancer that has spread have only a 3% survival rate or only 3 out of 100 people live at least 5 years after diagnosis.

Using Survival Rates

Now that you understand, what Lung Cancer Survival Rate statistics means you can begin to understand how they may be used.

The most common use is to help patients understand what lies ahead for them in dealing with the disease and the possibility of their death.

About the Author: